Cingulate Stock Performance

CING Stock  USD 3.93  0.23  5.53%   
The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cingulate are expected to decrease at a much lower rate. During the bear market, Cingulate is likely to outperform the market. At this point, Cingulate has a negative expected return of -0.25%. Please make sure to confirm Cingulate's treynor ratio, as well as the relationship between the daily balance of power and price action indicator , to decide if Cingulate performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
(2.12)
Five Day Return
(1.42)
Year To Date Return
(18.43)
Ten Year Return
(99.61)
All Time Return
(99.61)
Last Split Factor
1:12
Last Split Date
2024-08-09
JavaScript chart by amCharts 3.21.15123456789101112132025FebMar -25-20-15-10-505
JavaScript chart by amCharts 3.21.15Cingulate Cingulate Dividend Benchmark Dow Jones Industrial
1
Final Study Completed for Cingulates Lead Asset CTx-1301
01/07/2025
2
Acquisition by Brams Matthew of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3
01/17/2025
3
Acquisition by Silva Raul R. of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3
01/22/2025
4
Cingulate Inc. adjusts executive compensation - Investing.com
01/24/2025
5
Acquisition by Schaffer Shane J. of 90000 shares of Cingulate at 1.79 subject to Rule 16b-3
01/31/2025
6
Cingulate CEO cleared of charges, retains board confidence - Investing.com
02/03/2025
7
Acquisition by Silva Raul R. of 17630 shares of Cingulate at 4.32 subject to Rule 16b-3
02/18/2025
8
Acquisition by Jennifer Callahan of 21140 shares of Cingulate at 4.32 subject to Rule 16b-3
02/20/2025
9
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301 On Track to File for FDA Approval Mid-2025
03/04/2025
10
Acquisition by Myers Laurie of 636 shares of Cingulate at 1.5715 subject to Rule 16b-3
03/05/2025
11
Acquisition by Myers Laurie of 17630 shares of Cingulate at 4.32 subject to Rule 16b-3
03/06/2025
12
HC Wainwright Reaffirms Buy Rating for Cingulate - Defense World
03/07/2025
13
Cingulate Boosts Cash Position with 12.2 Million in Reserves
03/27/2025
Begin Period Cash Flow52.42
  

Cingulate Relative Risk vs. Return Landscape

If you would invest  505.00  in Cingulate on January 3, 2025 and sell it today you would lose (89.00) from holding Cingulate or give up 17.62% of portfolio value over 90 days. Cingulate is currently does not generate positive expected returns and assumes 3.6073% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Cingulate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketCING 0.00.51.01.52.02.53.03.54.0 -0.30-0.25-0.20-0.15-0.10-0.050.00
       Risk  
Given the investment horizon of 90 days Cingulate is expected to under-perform the market. In addition to that, the company is 4.11 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of volatility.

Cingulate Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0704

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCING

Estimated Market Risk

 3.61
  actual daily
32
68% of assets are more volatile

Expected Return

 -0.25
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cingulate is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding Cingulate to a well-diversified portfolio.

Cingulate Fundamentals Growth

Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.
Return On Equity-6.02
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Return On Asset-1.04
Current Valuation8.06 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-30%-20%-10%
Shares Outstanding3.65 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%50%
Price To Book2.04 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Gross Profit(9.45 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%350%
EBITDA(15.64 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%
Net Income(15.55 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%
Cash And Equivalents8.2 M
Cash Per Share0.73 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%2,500%3,000%3,500%
Total Debt2.53 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%
Debt To Equity0.08 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Current Ratio10.94 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%1,000%2,000%3,000%4,000%
Book Value Per Share2.19 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%20,000%40,000%60,000%80,000%
Cash Flow From Operations(18.45 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%0%20%40%60%80%100%
Earnings Per Share(10.20) X
Market Capitalization15.17 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-70%-60%-50%-40%-30%-20%-10%
Total Asset17.41 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50,000%100,000%150,000%200,000%250,000%300,000%350,000%
Retained Earnings(108.49 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%
Working Capital7.69 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31

About Cingulate Performance

By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(10.53)(10.00)
Return On Equity 3.08  3.24 

Things to note about Cingulate performance evaluation

Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cingulate generated a negative expected return over the last 90 days
Cingulate has high historical volatility and very poor performance
Net Loss for the year was (15.55 M) with loss before overhead, payroll, taxes, and interest of (9.45 M).
Cingulate currently holds about 8.2 M in cash with (18.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Latest headline from gurufocus.com: Cingulate Boosts Cash Position with 12.2 Million in Reserves
Evaluating Cingulate's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cingulate's stock performance include:
  • Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
  • Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cingulate's stock performance is not an exact science, and many factors can impact Cingulate's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm